Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by University of Alabama at Birmingham
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Bruce Korf, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01767792
First received: January 7, 2013
Last updated: December 2, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)